A recent memo from Dr. Vinay Prasad​, the head of the FDA's Center for Biologics Evaluation and Research, may signal an ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

The plan, which is not finalized, suggests children get fewer shots and shifts to a model telling parents to consult doctors ...

After a senior Food and Drug Administration official sent an internal email claiming that Covid vaccines had caused the deaths of “at least 10 children,” 12 former FDA commissioners released an ...

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...

Biostatistician Jeffrey Morris discusses his analysis of the vaccine monitoring system — and how it could be improved.

The US Department of Health and Human Services is planning to overhaul the schedule of recommended vaccines for children in ...

The Trump administration has announced sweeping policies that, if enacted, could effectively end gender-affirming care for ...

A monkeypox vaccine or antibody therapy may have taken a step closer to reality, as AI reveals new drug target.

As 2025 closes, biopharma and healthcare are learning to live on shifting ground. | Fierce reporters break down the forces that shaped biopharma and healthcare in 2025 and what lies ahead in 2026.

UNC's Barry Popkin joins Aaron to discuss the health impacts of "ultra-processed foods" and what policymakers should be doing ...

Dr. Vinay Prasad: "The establishment, the people who set the policies, they have to strive to get things right. They need to do studies. They need to be held to the highest standard." ...